← All companies

ONMD

OneMedNet Corporation

ONMDW Nasdaq Services-Commercial Physical & Biological Research EDGAR ↗

$0.04

+0.00 0.00%

Key statistics

from XBRL data in SEC filings

Market cap

$2.34M

Revenue (TTM)

$1.32M

Net income (TTM)

-$3.35M

EPS (TTM)

$-0.04

P/E ratio

—

Dividend yield

—

Free cash flow

-$7.52M

Cash

$233K

Total assets

$1.51M

Gross margin

-50.0%

52-week range

$0.04 – $0.04

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Item 5.08; Other events Jul 24, 2026 8-K Entered a material agreement Jul 1, 2026 10-Q Quarter ended 2026-03-31 May 15, 2026 10-K/A Fiscal year ended 2025-12-31 Apr 30, 2026 8-K Delisting notice or listing-rule failure Apr 20, 2026 10-K Fiscal year ended 2025-12-31 Mar 30, 2026 8-K Shareholder vote results; Other events Dec 23, 2025 10-Q Quarter ended 2025-09-30 Nov 14, 2025 8-K Director or officer change Nov 7, 2025 8-K Other events Oct 9, 2025 8-K Other events Sep 15, 2025 10-Q Quarter ended 2025-06-30 Aug 13, 2025 8-K Regulation FD disclosure Jul 11, 2025 8-K Regulation FD disclosure Jul 8, 2025 8-K Entered a material agreement; Unregistered sale of equity; Other events Jun 24, 2025 10-Q Quarter ended 2025-03-31 May 14, 2025 8-K Delisting notice or listing-rule failure Apr 15, 2025 10-K Fiscal year ended 2024-12-31 Apr 15, 2025 8-K Delisting notice or listing-rule failure Mar 14, 2025 8-K Director or officer change Mar 3, 2025 8-K Director or officer change Feb 6, 2025 8-K Regulation FD disclosure Dec 30, 2024 8-K Shareholder vote results Dec 20, 2024 10-Q Quarter ended 2024-09-30 Dec 17, 2024 10-Q Quarter ended 2024-06-30 Dec 11, 2024 10-Q Quarter ended 2024-03-31 Dec 5, 2024 8-K Delisting notice or listing-rule failure Nov 27, 2024 8-K/A Nov 22, 2024 10-K/A Fiscal year ended 2023-12-31 Nov 5, 2024 8-K Previously issued financials not reliable Nov 5, 2024 8-K Delisting notice or listing-rule failure Oct 17, 2024 8-K Delisting notice or listing-rule failure Oct 15, 2024 8-K Director or officer change; Regulation FD disclosure Oct 7, 2024 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Oct 1, 2024 8-K Delisting notice or listing-rule failure Sep 12, 2024 8-K Director or officer change Aug 30, 2024 8-K Delisting notice or listing-rule failure Aug 16, 2024 8-K Director or officer change Aug 14, 2024 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Jul 29, 2024 8-K Delisting notice or listing-rule failure Jun 24, 2024